AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11423808 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective head and shoulder equipment (pads group)
Number of subjects: 20
Study 11423808 — intervention group
Group type: COMPARATOR
Intervention: No protective equipment (no pads group)
Number of subjects: 20
Study 9125637 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg capsule with water
Number of subjects: 11
Study 9125637 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole granules with orange juice
Number of subjects: 11
Study 9125637 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole granules with Alka-Seltzer solution
Number of subjects: 11
Study 9125637 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole granules with apple sauce
Number of subjects: 11
Study 8238221 — intervention group
Group type: EXPERIMENTAL
Intervention: Carteolol 1.0% (one drop twice daily in both eyes)
Number of subjects: 58
Study 8238221 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol 0.5% (one drop twice daily in both eyes)
Number of subjects: 58
Study 3517284 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine (4 g/d)
Number of subjects: 80
Study 3517284 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital (7.5 to 10 mg/kg/d)
Number of subjects: 80
Study 3517284 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 80
Study 31910669 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic CT-MPI+CCTA-guided strategy
Number of subjects: 240
Study 31910669 — intervention group
Group type: COMPARATOR
Intervention: CCTA-guided strategy
Number of subjects: 240
Study 31910669 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 240
Study 30425469 — intervention group
Group type: COMPARATOR
Intervention: CHF6001 (20, 100, 200, 400, 800, 1,600, and 2,000 µg) via SDDPI
Number of subjects: 2
Study 30425469 — intervention group
Group type: COMPARATOR
Intervention: CHF6001 (2,400, 4,000, and 4,800 µg) via MDDPI
Number of subjects: 2
Study 30425469 — intervention group
Group type: COMPARATOR
Intervention: CHF6001 (100, 300, 600, 1,200, and 1,600 µg) once daily via SDDPI
Number of subjects: 2
Study 30425469 — intervention group
Group type: COMPARATOR
Intervention: CHF6001 (1,200, 2,000, or 2,400 µg) twice daily via MDDPI
Number of subjects: 2
Study 30425469 — intervention group
Group type: EXPERIMENTAL
Intervention: CHF6001
Number of subjects: 2
Study 27448534 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher loop diuretic doses during hospitalization
Number of subjects: 121
Study 24695771 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education intervention (1 face-to-face session, 2 follow-up calls, 3 pamphlets)
Number of subjects: 56
Study 24695771 — intervention group
Group type: COMPARATOR
Intervention: Usual care (handouts with guidelines on healthy eating)
Number of subjects: 56
Study 24695771 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education intervention
Number of subjects: 56
Study 22529085 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile-bearing prostheses
Number of subjects: 55
Study 22529085 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-bearing prostheses
Number of subjects: 55
Study 20456831 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-maximal exercise (cycling at 70% VO(2max) intensity until exhaustion)
Number of subjects: 0
Study 20456831 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise trial (seated for the duration of the experiment)
Number of subjects: 0
Study 20456831 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-maximal exercise
Number of subjects: 0
Study 17852636 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (15 mg) + Betamethasone (3 mg) weekly
Number of subjects: 40
Study 17852636 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (15 mg) weekly
Number of subjects: 40
Study 16051542 — intervention group
Group type: EXPERIMENTAL
Intervention: Qi-therapy (external Qigong) for four weeks
Number of subjects: 43
Study 16051542 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 43
Study 16051542 — intervention group
Group type: EXPERIMENTAL
Intervention: Qi-therapy (external Qigong)
Number of subjects: 43
Study 12030598 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD children
Number of subjects: 22
Study 12030598 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study 10024861 — intervention group
Group type: EXPERIMENTAL
Intervention: Staples, close immediately
Number of subjects: 77
Study 10024861 — intervention group
Group type: EXPERIMENTAL
Intervention: Staples, close after protamine administration
Number of subjects: 77
Study 10024861 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcuticular sutures, close immediately
Number of subjects: 77
Study 10024861 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcuticular sutures, close after protamine
Number of subjects: 77
Study 11563407 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg oral fosinopril
Number of subjects: 12
Study 11563407 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg IV fosinoprilat
Number of subjects: 12
Study 11563407 — intervention group
Group type: COMPARATOR
Intervention: Comparison to Western control group
Number of subjects: 12
Study 1854169 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (200 to 300 mg every 12 h)
Number of subjects: 101
Study 1854169 — intervention group
Group type: COMPARATOR
Intervention: Piperacillin plus amikacin
Number of subjects: 101
Study 1854169 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 101
Study 6364886 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesterolone (75 mg/day)
Number of subjects: 59
Study 6364886 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 6364886 — intervention group
Group type: EXPERIMENTAL
Intervention: Testicular biopsy score
Number of subjects: 59
Study 6364886 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesterolone
Number of subjects: 59
Study 31521646 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 24354
Study 31521646 — intervention group
Group type: COMPARATOR
Intervention: Non-smokers (control group)
Number of subjects: 24354
Study 31521646 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking status (as a predictor)
Number of subjects: 24354
Study 30593267 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Carbohydrate (HC) meal
Number of subjects: 46
Study 30593267 — intervention group
Group type: COMPARATOR
Intervention: Normo-Carbohydrate (NC) meal
Number of subjects: 46
Study 30593267 — intervention group
Group type: COMPARATOR
Intervention: High-Fat (HF) meal
Number of subjects: 46
Study 26147898 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol at BAC of approximately 0.5 g/L
Number of subjects: 20
Study 26147898 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol at BAC of approximately 0.9 g/L
Number of subjects: 20
Study 26147898 — intervention group
Group type: COMPARATOR
Intervention: Sober condition (0 g/L BAC)
Number of subjects: 20
Study 26147898 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator driving with ethanol
Number of subjects: 20
Study 26147898 — intervention group
Group type: COMPARATOR
Intervention: Test track driving with ethanol
Number of subjects: 20
Study 26147898 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard deviation of lateral position (SDLP)
Number of subjects: 20
Study 26147898 — intervention group
Group type: EXPERIMENTAL
Intervention: Other driving-related measures
Number of subjects: 20
Study 23929664 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth problem-solving therapy (tele-PST)
Number of subjects: 42
Study 22819521 — intervention group
Group type: COMPARATOR
Intervention: Budesonide 800 μg/d
Number of subjects: 26
Study 22819521 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 400 μg/d plus montelukast 10 mg/d
Number of subjects: 26
Study 20119873 — intervention group
Group type: EXPERIMENTAL
Intervention: Referenced decision aid
Number of subjects: 108
Study 20119873 — intervention group
Group type: COMPARATOR
Intervention: Anonymous pulmonologist
Number of subjects: 108
Study 17894791 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented transfusion strategy (transfusion of 2 units of RBCs when Hb < 120 g/L)
Number of subjects: 60
Study 17894791 — intervention group
Group type: COMPARATOR
Intervention: Standard transfusion strategy (transfusion of 2 units of RBCs when Hb < 80 g/L)
Number of subjects: 60
Study 17894791 — intervention group
Group type: EXPERIMENTAL
Intervention: Control and experimental groups
Number of subjects: 60
Study 16145532 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconstruction of the iliac crest with commercially available tricalcium phosphate bone void filler
Number of subjects: 30
Study 16145532 — intervention group
Group type: COMPARATOR
Intervention: No graft site reconstruction
Number of subjects: 30
Study 12032650 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish advice
Number of subjects: 1030
Study 12032650 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat and fibre advice
Number of subjects: 1030
Study 12032650 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat advice
Number of subjects: 1030
Study 10486649 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy
Number of subjects: 25
Study 10486649 — intervention group
Group type: COMPARATOR
Intervention: No estrogen replacement therapy (Control)
Number of subjects: 25
Study 8564101 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline 7.5 mg twice a day for 2 weeks
Number of subjects: 30
Study 8564101 — intervention group
Group type: COMPARATOR
Intervention: Budesonide 400 micrograms twice a day by inhalation
Number of subjects: 30
Study 8564101 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone 40 mg orally 12 h before second examination
Number of subjects: 30
Study 8564101 — intervention group
Group type: COMPARATOR
Intervention: Placebo orally 12 h before second examination
Number of subjects: 30
Study 8564101 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline treatment
Number of subjects: 30
Study 1920340 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (25 mg twice daily)
Number of subjects: 27
Study 1920340 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine AR (20 mg twice daily)
Number of subjects: 27
Study 1920340 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 tab twice daily)
Number of subjects: 27
Study 7045292 — intervention group
Group type: EXPERIMENTAL
Intervention: Disopyramide
Number of subjects: 10
Study 7045292 — intervention group
Group type: COMPARATOR
Intervention: Procainamide
Number of subjects: 10
Study 31792485 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined orthodontic treatment and conventional periodontal splint (experimental group)
Number of subjects: 50
Study 31792485 — intervention group
Group type: COMPARATOR
Intervention: Conventional periodontal splint (control group)
Number of subjects: 50
Study 29065885 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher serum bilirubin concentrations (measured prior to first AECOPD) in the STATCOPE study (n=853)
Number of subjects: 1871
Study 29065885 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher serum bilirubin concentrations (measured prior to first AECOPD) in the MACRO study (n=1018)
Number of subjects: 1871
Study 24965797 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive behavioral therapy (TF-CBT)
Number of subjects: 48
Study 24965797 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye movement desensitization and reprocessing (EMDR)
Number of subjects: 48
Study 23364500 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor nutritional status (measured by Mini Nutritional Assessment - MNA)
Number of subjects: 188
Study 23364500 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary tract infection (UTI)
Number of subjects: 188
Study 23364500 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive status (measured by Mini Mental State Examination - MMSE)
Number of subjects: 188
Study 23364500 — intervention group
Group type: EXPERIMENTAL
Intervention: Dependence in feeding
Number of subjects: 188
Study 21978518 — intervention group
Group type: EXPERIMENTAL
Intervention: Total disc replacement (TDR)
Number of subjects: 152
Study 21978518 — intervention group
Group type: COMPARATOR
Intervention: Fusion
Number of subjects: 152
Study 19852337 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective re-siting of intravenous cannulae every 48 hours
Number of subjects: 42
Study 19852337 — intervention group
Group type: COMPARATOR
Intervention: Control group with cannulae removed only if painful, dislodged, or showing signs of PVT
Number of subjects: 42
Study 17572322 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-minute group (2 L/min oxygen and 4 L/min nitrous oxide for 1 minute)
Number of subjects: 53
Study 17572322 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-minute group (2 L/min oxygen and 4 L/min nitrous oxide for 2 minutes)
Number of subjects: 53
Study 17572322 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-minute group (2 L/min oxygen and 4 L/min nitrous oxide for 3 minutes)
Number of subjects: 53
Study 17572322 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-minute group (2 L/min oxygen and 4 L/min nitrous oxide for 5 minutes)
Number of subjects: 53
Study 15635511 — intervention group
Group type: EXPERIMENTAL
Intervention: Median nerve response (group 1)
Number of subjects: 130
Study 15635511 — intervention group
Group type: COMPARATOR
Intervention: Musculocutaneous nerve response (group 2)
Number of subjects: 130
Study 12199264 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (1,800 to 3,600 mg/day)
Number of subjects: 0
Study 12199264 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 0
Study 9667260 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin AUC 6 for six courses, administered every 28 days
Number of subjects: 227
Study 9667260 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin AUC 12 for four courses, administered every 28 days
Number of subjects: 227
Study 9667260 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin AUC 12
Number of subjects: 227
Study 9667260 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin AUC 6
Number of subjects: 227
Study 7853812 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum lipoprotein spectrum evaluation in patients with cholelithiasis
Number of subjects: 63
Study 7853812 — intervention group
Group type: EXPERIMENTAL
Intervention: Correction of dyslipoproteinemia
Number of subjects: 63
Study 7853812 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 63
Study 15374499 — intervention group
Group type: EXPERIMENTAL
Intervention: Centrophenoxine (CPH), 2 g/day for 8 weeks
Number of subjects: 50
Study 15374499 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 50
Study 7364818 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalothin
Number of subjects: 307
Study 30426525 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand cream dispensers equipped with an electronic system to monitor use, communicated regularly to HCWs via posters.
Number of subjects: 501
Study 30426525 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) without the electronic monitoring and feedback intervention.
Number of subjects: 501
Study 28407662 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day fasting program with 300 kcal/day by liquids only
Number of subjects: 32
Study 28407662 — intervention group
Group type: COMPARATOR
Intervention: Usual care and dietary advice only
Number of subjects: 32
Study 25743732 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle strength training program (50 minutes, twice a week for 8 weeks, including Kegel's exercise, Thera-band training, and indoor walking)
Number of subjects: 70
Study 23531715 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HI) at 80%-90% maximal workload
Number of subjects: 23
Study 23531715 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity interval training (MOD) at 60%-80% maximal workload
Number of subjects: 23
Study 23531715 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HI)
Number of subjects: 23
Study 23531715 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity interval training (MOD)
Number of subjects: 23
Study 23531715 — intervention group
Group type: COMPARATOR
Intervention: Control group (7 women)
Number of subjects: 23
Study 22802072 — intervention group
Group type: EXPERIMENTAL
Intervention: STEPP program
Number of subjects: 80
Study 19699385 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose N-acetylcysteine (daily dose > 1200 mg or single dose > 600 mg within 4 hours of contrast exposure)
Number of subjects: 1677
Study 19699385 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1677
Study 17533518 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal expanding balloon (FB)
Number of subjects: 122
Study 17533518 — intervention group
Group type: COMPARATOR
Intervention: Conventional unidiameter balloon (UB)
Number of subjects: 122
Study 15211249 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanic acid administered for 7 days
Number of subjects: 520
Study 15211249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 520
Study 15211249 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanic acid
Number of subjects: 520
Study 11359340 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative duplex scanning
Number of subjects: 176
Study 9874902 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-focused cognitive-behavioral therapy (CBT)
Number of subjects: 67
Study 9874902 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-focused cognitive-behavioral therapy (CBT) plus parental anxiety management (CBT + PAM)
Number of subjects: 67
Study 9874902 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-focused cognitive-behavioral therapy (CBT + PAM)
Number of subjects: 67
Study 7979494 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebuhaler (750 ml)
Number of subjects: 20
Study 7979494 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerochamber (140 ml)
Number of subjects: 20
Study 7979494 — intervention group
Group type: EXPERIMENTAL
Intervention: Babyspacer (260 ml)
Number of subjects: 20
Study 2482007 — intervention group
Group type: EXPERIMENTAL
Intervention: casein-predominant low protein formula
Number of subjects: 70
Study 2482007 — intervention group
Group type: COMPARATOR
Intervention: humanized formula
Number of subjects: 70
Study 2482007 — intervention group
Group type: COMPARATOR
Intervention: special low-birthweight formula
Number of subjects: 70
Study 403557 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (120 mg per os)
Number of subjects: 6
Study 403557 — intervention group
Group type: EXPERIMENTAL
Intervention: Marihuana (10 mg delta9-THC)
Number of subjects: 6
Study 403557 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol + Marihuana
Number of subjects: 6
Study 29888541 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interview (MI)
Number of subjects: 40
Study 28917225 — intervention group
Group type: EXPERIMENTAL
Intervention: iEAT diet
Number of subjects: 50
Study 28917225 — intervention group
Group type: COMPARATOR
Intervention: modified traditional diet (control)
Number of subjects: 50
Study 25792124 — intervention group
Group type: EXPERIMENTAL
Intervention: Vorapaxar
Number of subjects: 20170
Study 23548443 — intervention group
Group type: EXPERIMENTAL
Intervention: One‐day CRM‐based classroom course
Number of subjects: 157
Study 23548443 — intervention group
Group type: EXPERIMENTAL
Intervention: One‐day CRM style simulation‐based training
Number of subjects: 157
Study 23548443 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom training followed by simulation‐based training
Number of subjects: 157
Study 23548443 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 157
Study 21298068 — intervention group
Group type: EXPERIMENTAL
Intervention: Light exposure at 6500K
Number of subjects: 16
Study 21298068 — intervention group
Group type: COMPARATOR
Intervention: Light exposure at 2500K
Number of subjects: 16
Study 21298068 — intervention group
Group type: COMPARATOR
Intervention: Incandescent lamps at 3000K
Number of subjects: 16
Study 19502673 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromobilization-based physiotherapy for two weeks
Number of subjects: 108
Study 19502673 — intervention group
Group type: COMPARATOR
Intervention: Standard physiotherapy for two weeks
Number of subjects: 108
Study 16729207 — intervention group
Group type: EXPERIMENTAL
Intervention: Identification latency of 10-12 seconds
Number of subjects: 0
Study 16729207 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall response latency under manipulations of retention interval and nominal lineup size
Number of subjects: 0
Study 14705107 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation and physical therapy (SCS+PT)
Number of subjects: 54
Study 14705107 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy (PT)
Number of subjects: 54
Study 12653375 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-page patient communication workbook received 2-3 days pre-visit
Number of subjects: 150
Study 12653375 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-page patient communication handout received in the waiting room
Number of subjects: 150
Study 12653375 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study 9259358 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased dialysis volume (0.5 L per exchange, total increase of 1.5 L daily)
Number of subjects: 35
Study 9259358 — intervention group
Group type: COMPARATOR
Intervention: Unchanged dialysis regimen (4 exchanges of 2 L per day)
Number of subjects: 35
Study 8279841 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg/day of cyclophosphamide for 3 months
Number of subjects: 0
Study 8279841 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide 500 mg/m2 + CDDP 75 mg/m2 every 4 weeks for 3 courses
Number of subjects: 0
Study 8279841 — intervention group
Group type: EXPERIMENTAL
Intervention: CP therapy (cyclophosphamide 600 mg/m2 + CDDP 75 mg/m2)
Number of subjects: 0
Study 8279841 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphadenectomy group
Number of subjects: 0
Study 8279841 — intervention group
Group type: COMPARATOR
Intervention: No-lymphadenectomy group
Number of subjects: 0